Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper

Levosimendan is an inodilator that promotes cardiac contractility primarily through calcium sensitization of cardiac troponin C and vasodilatation via opening of adenosine triphosphate–sensitive potassium (K(ATP)) channels in vascular smooth muscle cells; the drug also exerts organ-protective effect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cardiovasc Pharmacol
Main Authors: Herpain, Antoine, Bouchez, Stefaan, Girardis, Massimo, Guarracino, Fabio, Knotzer, Johann, Levy, Bruno, Liebregts, Tobias, Pollesello, Piero, Ricksten, Sven-Erik, Riha, Hynek, Rudiger, Alain, Sangalli, Fabio
Formato: Artigo
Idioma:Inglês
Publicado em: Journal of Cardiovascular Pharmacology 2019
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6319595/
https://ncbi.nlm.nih.gov/pubmed/30489437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0000000000000636
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados